EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression

PLoS Pathogens

Volumn 12, Issue 5, 2016, Pages

  Currier, Michael G ^a,b   Lee, Sujin ^a,b   Stobart, Christopher C ^a,b   Hotard, Anne L ^a,b,h   Villenave, Remi ^c,i   Meng, Jia ^a,b,j   Pretto, Carla D ^a,b,k   Shields, Michael D ^c,d   Nguyen, Minh Trang ^a,b   Todd, Sean O ^a,b   Chi, Michael H ^e,l   Hammonds, Jason ^a,b   Krumm, Stefanie A ^f,m   Spearman, Paul ^a,b   Plemper, Richard K ^f   Sakamoto, Kaori ^g   Peebles, R Stokes ^e   Power, Ultan F ^c   Moore, Martin L ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d ROYAL BELFAST HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f GEORGIA STATE UNIVERSITY   (United States)

^g UNIVERSITY OF GEORGIA   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁱ HARVARD UNIVERSITY   (United States)

^j AliosBiopharma   (United States)

^k UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^l VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^m KING'S COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; MUCIN; MUCIN 5AC; VIRUS FUSION PROTEIN; EGFR PROTEIN, MOUSE; F PROTEIN, HUMAN RESPIRATORY SYNCYTIAL VIRUS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING; LUCIFERASE ASSAY; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS STRAIN 2-20; RNA ISOLATION; VIRUS INFECTION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; DISEASE MODEL; FLUORESCENT ANTIBODY TECHNIQUE; GENE SILENCING; METABOLISM; RESPIRATORY SYNCYTIAL VIRUS INFECTION;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE KNOCKDOWN TECHNIQUES; IMMUNOPRECIPITATION; MICE; MICE, INBRED BALB C; MUCINS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; VIRAL FUSION PROTEINS;

EID: 84973352672     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005622     Document Type: Article

References (64)

1. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, et al. (2009) The burden of respiratory syncytial virus infection in young children. N Engl J Med360: 588–598. doi: 10.1056/NEJMoa080487719196675
2. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, et al. (2010) Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet375: 1545–1555. doi: 10.1016/S0140-6736(10)60206-120399493
3. Tayyari F, Marchant D, Moraes TJ, Duan W, Mastrangelo P, et al. (2011) Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat Med17: 1132–1135. doi: 10.1038/nm.244421841784
4. Feldman SA, Hendry RM, Beeler JA, (1999) Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. J Virol73: 6610–6617. 10400758
5. San-Juan-Vergara H, Sampayo-Escobar V, Reyes N, Cha B, Pacheco-Lugo L, et al. (2012) Cholesterol-rich microdomains as docking platforms for respiratory syncytial virus in normal human bronchial epithelial cells. J Virol86: 1832–1843. doi: 10.1128/JVI.06274-1122090136
6. Tripp RA, Jones LP, Haynes LM, Zheng H, Murphy PM, et al. (2001) CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol2: 732–738. 11477410
7. Chirkova T, Lin S, Oomens AG, Gaston KA, Boyoglu-Barnum S, et al. (2015) CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells. J Gen Virol96: 2543–2556. doi: 10.1099/vir.0.00021826297201
8. Jeong KI, Piepenhagen PA, Kishko M, DiNapoli JM, Groppo RP, et al. (2015) CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent Manner. PLoS One10: e0130517. doi: 10.1371/journal.pone.013051726107373
9. Johnson SM, McNally BA, Ioannidis I, Flano E, Teng MN, et al. (2015) Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures. PLoS Pathog11: e1005318. doi: 10.1371/journal.ppat.100531826658574
10. Walsh EE, Hruska J, (1983) Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein. J Virol47: 171–177. 6345804
11. McLellan JS, Chen M, Leung S, Graepel KW, Du X, et al. (2013) Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody. Science.
12. Zhao X, Singh M, Malashkevich VN, Kim PS, (2000) Structural characterization of the human respiratory syncytial virus fusion protein core. Proc Natl Acad Sci U S A97: 14172–14177. 11106388
13. McLellan JS, Yang Y, Graham BS, Kwong PD, (2011) Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes. J Virol85: 7788–7796. doi: 10.1128/JVI.00555-1121613394
14. Wertz GW, Collins PL, Yung HA, Gruber C, Levine S, et al. (1985) Nucleotide-Sequence of the G-Protein Gene of Human Respiratory Syncytial Virus Reveals an Unusual Type of Viral Membrane-Protein. Proceedings of the National Academy of Sciences of the United States of America82: 4075–4079. 3858865
15. Wertz GW, Krieger M, Ball LA, (1989) Structure and cell surface maturation of the attachment glycoprotein of human respiratory syncytial virus in a cell line deficient in O glycosylation. J Virol63: 4767–4776. 2677404
16. Teng MN, Whitehead SS, Collins PL, (2001) Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo. Virology289: 283–296. 11689051
17. Techaarpornkul S, Collins PL, Peeples ME, (2002) Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus. Virology294: 296–304. 12009871
18. Meng J, Hotard AL, Currier MG, Lee S, Stobart CC, et al. (2015) Respiratory Syncytial Virus Attachment Glycoprotein Contribution to Infection Depends on the Specific Fusion Protein. J Virol90: 245–253. doi: 10.1128/JVI.02140-1526468535
19. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, et al. (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature309: 418–425. 6328312
20. Downward J, Parker P, Waterfield MD, (1984) Autophosphorylation sites on the epidermal growth factor receptor. Nature311: 483–485. 6090945
21. Miller WE, Earp HS, Raab-Traub N, (1995) The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J Virol69: 4390–4398. 7769701
22. Menzo S, Clementi M, Alfani E, Bagnarelli P, Iacovacci S, et al. (1993) Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product. Virology196: 878–882. 8396816
23. Wang X, Huong SM, Chiu ML, Raab-Traub N, Huang ES, (2003) Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature424: 456–461. 12879076
24. Monick MM, Cameron K, Staber J, Powers LS, Yarovinsky TO, et al. (2005) Activation of the epidermal growth factor receptor by respiratory syncytial virus results in increased inflammation and delayed apoptosis. J Biol Chem280: 2147–2158. 15542601
25. Kalinowski A, Ueki I, Min-Oo G, Ballon-Landa E, Knoff D, et al. (2014) EGFR activation suppresses respiratory virus-induced IRF1-dependent CXCL10 production. Am J Physiol Lung Cell Mol Physiol307: L186–196. doi: 10.1152/ajplung.00368.201324838750
26. Krzyzaniak MA, Zumstein MT, Gerez JA, Picotti P, Helenius A, (2013) Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein. PLoS Pathog9: e1003309. doi: 10.1371/journal.ppat.100330923593008
27. Stokes KL, Chi MH, Sakamoto K, Newcomb DC, Currier MG, et al. (2011) Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice. J Virol85: 5782–5793. doi: 10.1128/JVI.01693-1021471228
28. Stokes KL, Currier MG, Sakamoto K, Lee S, Collins PL, et al. (2013) The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection. J Virol87: 10070–10082. doi: 10.1128/JVI.01347-1323843644
29. Barbier D, Garcia-Verdugo I, Pothlichet J, Khazen R, Descamps D, et al. (2012) Influenza A induces the major secreted airway mucin MUC5AC in a protease-EGFR-extracellular regulated kinase-Sp1-dependent pathway. Am J Respir Cell Mol Biol47: 149–157. doi: 10.1165/rcmb.2011-0405OC22383584
30. Hewson CA, Haas JJ, Bartlett NW, Message SD, Laza-Stanca V, et al. (2010) Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-kappaB and EGFR pathways. Eur Respir J36: 1425–1435. doi: 10.1183/09031936.0002691020525715
31. Amann J, Kalyankrishna S, Massion PP, Ohm JE, Girard L, et al. (2005) Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer. Cancer Res65: 226–235. 15665299
32. Humtsoe JO, Kramer RH, (2010) Differential epidermal growth factor receptor signaling regulates anchorage-independent growth by modulation of the PI3K/AKT pathway. Oncogene29: 1214–1226. doi: 10.1038/onc.2009.41919935697
33. Kondo N, Miyauchi K, Meng F, Iwamoto A, Matsuda Z, (2010) Conformational changes of the HIV-1 envelope protein during membrane fusion are inhibited by the replacement of its membrane-spanning domain. J Biol Chem285: 14681–14688. doi: 10.1074/jbc.M109.06709020197275
34. Baviskar PS, Hotard AL, Moore ML, Oomens AG, (2013) The respiratory syncytial virus fusion protein targets to the perimeter of inclusion bodies and facilitates filament formation by a cytoplasmic tail-dependent mechanism. J Virol87: 10730–10741. doi: 10.1128/JVI.03086-1223903836
35. Takeyama K, Dabbagh K, Lee HM, Agusti C, Lausier JA, et al. (1999) Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci U S A96: 3081–3086. 10077640
36. Stanciu LA, Bellettato CM, Laza-Stanca V, Coyle AJ, Papi A, et al. (2006) Expression of programmed death-1 ligand (PD-L) 1, PD-L2, B7-H3, and inducible costimulator ligand on human respiratory tract epithelial cells and regulation by respiratory syncytial virus and type 1 and 2 cytokines. J Infect Dis193: 404–412. 16388488
37. Perini AP, Barbosa ML, Botosso VF, de Moraes CT, Gillio AE, et al. (2007) Comparison of HeLa-I, HEp-2 and NCI-H292 cell lines for the isolation of human respiratory syncytial virus (HRSV). J Virol Methods146: 368–371. 17825929
38. Meng J, Lee S, Hotard AL, Moore ML, (2014) Refining the balance of attenuation and immunogenicity of respiratory syncytial virus by targeted codon deoptimization of virulence genes. MBio5: e01704–01714. doi: 10.1128/mBio.01704-1425249281
39. Gundavarapu S, Mishra NC, Singh SP, Langley RJ, Saeed AI, et al. (2013) HIV gp120 induces mucus formation in human bronchial epithelial cells through CXCR4/alpha7-nicotinic acetylcholine receptors. PLoS One8: e77160. doi: 10.1371/journal.pone.007716024155926
40. Nakamura T, Peng KW, Harvey M, Greiner S, Lorimer IA, et al. (2005) Rescue and propagation of fully retargeted oncolytic measles viruses. Nat Biotechnol23: 209–214. 15685166
41. Huang K, Incognito L, Cheng X, Ulbrandt ND, Wu H, (2010) Respiratory syncytial virus-neutralizing monoclonal antibodies motavizumab and palivizumab inhibit fusion. J Virol84: 8132–8140. doi: 10.1128/JVI.02699-0920519399
42. McLellan JS, Chen M, Kim A, Yang Y, Graham BS, et al. (2010) Structural basis of respiratory syncytial virus neutralization by motavizumab. Nat Struct Mol Biol17: 248–250. doi: 10.1038/nsmb.172320098425
43. Lukacs NW, Moore ML, Rudd BD, Berlin AA, Collins RD, et al. (2006) Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus. Am J Pathol169: 977–986. 16936271
44. Moore ML, Chi MH, Luongo C, Lukacs NW, Polosukhin VV, et al. (2009) A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction. J Virol83: 4185–4194. doi: 10.1128/JVI.01853-0819211758
45. Villenave R, Thavagnanam S, Sarlang S, Parker J, Douglas I, et al. (2012) In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo. Proc Natl Acad Sci U S A109: 5040–5045. doi: 10.1073/pnas.111020310922411804
46. Piatkevich KD, Hulit J, Subach OM, Wu B, Abdulla A, et al. (2010) Monomeric red fluorescent proteins with a large Stokes shift. Proc Natl Acad Sci U S A107: 5369–5374. doi: 10.1073/pnas.091436510720212155
47. Kirkham S, Sheehan JK, Knight D, Richardson PS, Thornton DJ, (2002) Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. Biochem J361: 537–546. 11802783
48. Kanai K, Koarai A, Shishikura Y, Sugiura H, Ichikawa T, et al. (2015) Cigarette smoke augments MUC5AC production via the TLR3-EGFR pathway in airway epithelial cells. Respir Investig53: 137–148. doi: 10.1016/j.resinv.2015.01.00726100173
49. Binker MG, Binker-Cosen MJ, Richards D, Binker-Cosen AA, Freedman SD, et al. (2015) Omega-3 PUFA docosahexaenoic acid decreases LPS-stimulated MUC5AC production by altering EGFR-related signaling in NCI-H292 cells. Biochem Biophys Res Commun463: 1047–1052. doi: 10.1016/j.bbrc.2015.06.05626079889
50. Kim TE, Murren JR, (2002) Erlotinib OSI/Roche/Genentech. Curr Opin Investig Drugs3: 1385–1395. 12498017
51. Aherne W, Bird T, Court SD, Gardner PS, McQuillin J, (1970) Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol23: 7–18. 4909103
52. Meng J, Stobart CC, Hotard AL, Moore ML, (2014) An overview of respiratory syncytial virus. PLoS Pathog10: e1004016. doi: 10.1371/journal.ppat.100401624763387
53. Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS, (2007) The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol20: 108–119. 17143259
54. Pickles RJ, DeVincenzo JP, (2015) Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis. J Pathol235: 266–276. doi: 10.1002/path.446225302625
55. American Academy of Pediatrics Subcommittee on D, Management of B (2006) Diagnosis and management of bronchiolitis. Pediatrics118: 1774–1793. 17015575
56. Ptaschinski C, Mukherjee S, Moore ML, Albert M, Helin K, et al. (2015) RSV-Induced H3K4 Demethylase KDM5B Leads to Regulation of Dendritic Cell-Derived Innate Cytokines and Exacerbates Pathogenesis In Vivo. PLoS Pathog11: e1004978. doi: 10.1371/journal.ppat.100497826083387
57. Krarup A, Truan D, Furmanova-Hollenstein P, Bogaert L, Bouchier P, et al. (2015) A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism. Nat Commun6: 8143.
58. Smith EC, Culler MR, Hellman LM, Fried MG, Creamer TP, et al. (2012) Beyond anchoring: the expanding role of the hendra virus fusion protein transmembrane domain in protein folding, stability, and function. J Virol86: 3003–3013. doi: 10.1128/JVI.05762-1122238302
59. Sauty A, Dziejman M, Taha RA, Iarossi AS, Neote K, et al. (1999) The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol162: 3549–3558. 10092813
60. Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, et al. (2011) Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med184: 662–671. doi: 10.1164/rccm.201104-0597OC21680942
61. Ishikawa H, Meng F, Kondo N, Iwamoto A, Matsuda Z, (2012) Generation of a dual-functional split-reporter protein for monitoring membrane fusion using self-associating split GFP. Protein Eng Des Sel25: 813–820. doi: 10.1093/protein/gzs05122942393
62. Hotard AL, Shaikh FY, Lee S, Yan D, Teng MN, et al. (2012) A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis. Virology434: 129–136. doi: 10.1016/j.virol.2012.09.02223062737
63. Paal T, Brindley MA, Clair C, StPrussia A, Gaus D, et al. (2009) Probing the spatial organization of measles virus fusion complexes. J Virol83: 10480–10493. doi: 10.1128/JVI.01195-0919656895
64. Hewson CA, Edbrooke MR, Johnston SL, (2004) PMA induces the MUC5AC respiratory mucin in human bronchial epithelial cells, via PKC, EGF/TGF-alpha, Ras/Raf, MEK, ERK and Sp1-dependent mechanisms. J Mol Biol344: 683–695. 15533438